Real Life Effectiveness of KASA: A Prospective Observational Cohort Study

Trial Profile

Real Life Effectiveness of KASA: A Prospective Observational Cohort Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 31 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 13 Jul 2016 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016.
    • 08 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top